What is the current price for "When will Compass Pathways submit a NDA for COMP360 psilocybin?"?

The leading outcome "Yes" is currently trading at 74.5% probability.

How many markets are available for "When will Compass Pathways submit a NDA for COMP360 psilocybin?"?

There are 6 markets available for this event on Kalshi.

What is the trading volume for "When will Compass Pathways submit a NDA for COMP360 psilocybin?"?

Trading volume data is not currently available.

When will Compass Pathways submit a NDA for COMP360 psilocybin?

Name: When will Compass Pathways submit a NDA for COMP360 psilocybin?
Start: 2026-04-19T06:35:31.113Z
End: 2026-05-19T06:35:31.113Z

Market Price Graph

6 markets tracked

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before April 2027)

kalshi

No data available

All Markets(6)

Market	Price
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before April 2027)	80%
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before 2027)	75%
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before December)	59%
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before November)	41%
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before October)	16%

Markets (6)

Sort

KALSHIHealth

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before April 2027)

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before 2027)

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before December)

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before November)

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before October)

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before September)

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.